华大九天：国家大基金、上海建元拟合计减持不超3.6%股份

Group 1 - The core point of the article is that two major shareholders of BGI Genomics (华大九天) plan to reduce their holdings, which may impact the company's stock performance [1] Group 2 - The National Integrated Circuit Industry Investment Fund, holding 8.34% of the shares, plans to reduce its stake by up to 10.9088 million shares, representing no more than 2% of the total share capital [1] - Shanghai Jianyuan, holding 6.55% of the shares, intends to reduce its stake by up to 8.727 million shares, accounting for no more than 1.6% of the total share capital [1]